Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio  

Jazz Pharmaceuticals to Acquire Chimerix

Today, March 5, 2025, Jazz Pharmaceuticals (JAZZ) and Chimerix (CMRX) announced the companies have entered into a definitive agreement for Jazz . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.